Dale Yuzuki


About Dale Yuzuki

A sales and marketing professional in the life sciences research-tools area, Dale currently is employed by SeqOnce Bioscienceshttps://seqonce.com as their Director of Business Development. For additional biographical information, please see my LinkedIn profile here: http://www.linkedin.com/in/daleyuzuki and also find me on Twitter @DaleYuzuki.

BinaxNOW COVID-19 Ag Card is the Beginning of the End

Abbott’s new $5, 15-minute, 50 million per month test is a game-changer This past week an eventful announcement came from Abbott Laboratories, manufacturer of several diagnostic platforms, including several already approved fro COVID-19 testing including amplification-based IDNow, and a few antibody automated systems, one prominent one being the Architect. Now […]


Screencap of http://sherlock.bio announcement of EUA approval

Sherlock Bio gets Emergency Use Authorization for CRISPR-based Diagnostics of SARS-CoV-2

It was about a year ago that I highlighted here some neat graphene technology out of Cardea Biosciences, and in that context I mentioned CRISPR-based diagnostics. (If interested, you can find the post here.) The FDA recently approved under Emergency Use Authorization (EUA) Sherlock BioSciences’ SARS-CoV-2 Rapid diagnostic (FDA EUA […]


Study suggests SARS-CoV-2 exposure is 50 to 85 times the COVID-19 cases in Santa Clara 2

One of the first serosurvey results from Santa Clara county in California reports 48,000 to 81,000 people infected, 50-fold to 85-fold more than the number of confirmed cases. Living through a pandemic while under lockdown order, with schools and routines and social events and music concerts and movie theaters and […]

Sample map of Santa Clara County

NIH starts serological survey testing anti-SARS-CoV-2 among the US population 2

Using both traditional blood draw and an innovative home-collection device, the NIH recruits 1000 healthy volunteers nationwide The SARS-CoV-2 virus (otherwise known as coronavirus, the causative virus of COVID-19 disease currently rampaging worldwide) is a difficult pathogen to battle. While clearing out my bursting-at-the-seams ‘downloads’ folder on my computer this […]


German Karneval goer ready to party

Serological testing in Germany shows resistance to coronavirus SARS-CoV-2 at 14 percent 3

First preliminary results from widespread IgA/IgG SARS-CoV-2 resistance antibody testing in Heinsberg Germany Being an active research scientist or having a life science research background during a once-in-a-lifetime worldwide epidemic is a remarkable thing. Whether reading pre-prints on MedRxiv or looking into the latest news of the day or reading […]